FAQ'S

Aquablation therapy is performed in a hospital. You will be under anesthesia for the entire procedure. The procedure typically takes less than an hour and involves an overnight stay.

There are two key steps to the procedure—creating a surgical map and removing the prostate tissue. For more details on the Aquablation procedure, visit the Aquablation Therapy page.

As with most BPH procedures, you will wake up with a catheter following Aquablation therapy, which allows you to urinate while your urethra heals. Patients typically stay overnight in the hospital. While no one likes staying overnight in a hospital, the benefit with Aquablation therapy is that most patients end up leaving the hospital without a catheter.^1,2,3

For more information on the Aquablation procedure and recovery, visit the Aquablation Therapy page.

References:
1. Gilling, P, et al. Three-Year Outcomes after Aquablation Therapy Compared to TURP: Results from a Blinded Randomized Trial. Can J Urol. 2020 Feb;27(1):10072-10079.
2. Bhojani, N, et al.  Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results. Urology. 2019 Jul;129:1-7.
3. Data on file at PROCEPT BioRobotics.

As with most BPH procedures, you will wake up with a catheter following Aquablation therapy, which allows you to urinate while your urethra heals. Patients typically stay overnight in the hospital. While no one likes staying overnight in a hospital, the benefit with Aquablation therapy is that most patients end up leaving the hospital without a catheter.^1,2,3

Once you’re home, you may experience mild burning during urination for a couple of weeks.  This can be managed with mild pain medication. Patients can resume their normal activities once approved by their doctor.

To find out more about recovery, visit the Aquablation Therapy page.

References:
1. Gilling, P, et al. Three-Year Outcomes after Aquablation Therapy Compared to TURP: Results from a Blinded Randomized Trial. Can J Urol. 2020 Feb;27(1):10072-10079.
2. Bhojani, N, et al.  Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results. Urology. 2019 Jul;129:1-7.
3. Data on file at PROCEPT BioRobotics.

Your urologist performs Aquablation therapy using the AquaBeam Robotic System. The procedure takes place in a hospital.

For more information, visit the Aquablation Therapy page.

Aquablation therapy is a one-of-a-kind procedure. It is the only procedure that uses a heat-free waterjet controlled by robotic technology to remove prostate tissue and combines a camera (called a cystoscope) with ultrasound imaging, giving the surgeon the ability to see the entire prostate in real time. As a result, Aquablation therapy is precise, consistent and predictable and provides long-term relief no matter how large your prostate is, and has a very low rate of irreversible complications—incontinence, ejaculatory dysfunction, erectile dysfunction.^1,2

For more information, visit our Aquablation Therapy page.

References:
1. Gilling, P, et al. Three-Year Outcomes after Aquablation Therapy Compared to TURP: Results from a Blinded Randomized Trial. Can J Urol. 2020 Feb;27(1):10072-10079.
2. Bhojani, N, et al.  Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results. Urology. 2019 Jul;129:1-7.

Aquablation therapy has been proven as a safe and effective treatment for patients suffering from lower urinary tract symptoms (LUTS) due to BPH. Aquablation therapy can be performed on prostates of any size.

Aquablation therapy is commercially available in the United States, Europe, the United Kingdom, the Middle East and Asia.

The most common side effects are mild and temporary. These may include mild pain, bleeding or strain while peeing, discomfort in the pelvis, inability to empty the bladder, a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum. For more information about potential side effects and risks associated with Aquablation therapy, speak with your urologist or surgeon.

For more information, visit the Safety Information page.

Yes, Aquablation therapy is performed by the AquaBeam Robotic System, which was cleared by the FDA in December 2017.

For more information, visit the Aquablation Therapy page.

Yes. Aquablation therapy is performed by the AquaBeam Robotic System, which received CE Mark in 2014.

For more information, visit the Aquablation Therapy page.

Aquablation therapy has a very low rate of irreversible complications (incontinence, ejaculatory dysfunction, erectile dysfunction).^1,2

For more information, visit the Aquablation Therapy page.

References:
1. Gilling, P, et al. Three-Year Outcomes after Aquablation Therapy Compared to TURP: Results from a Blinded Randomized Trial. Can J Urol. 2020 Feb;27(1):10072-10079.
2. Bhojani, N, et al.  Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results. Urology. 2019 Jul;129:1-7.

Aquablation therapy has been studied in nine different clinical trials. It has been shown to be a safe and effective treatment for patients suffering from lower urinary tract symptoms (LUTS) due to BPH.

For more information, visit the Aquablation Therapy page.

References:
1. NCT03191734 – French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue
2. NCT03123250 – Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II (WATERII)
3. NCT02974751 – Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (OPEN WATER)
4. NCT02505919 -Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
5. NCT03167294 – AquaBeam India Study for the Treatment of Benign Prostatic Hyperplasia (ABS)
6. NCT03125863 – Acute Hemostasis Following the Use of the AquaBeam® System for the Treatment of Benign Prostatic Hyperplasia (AHA)
7. NCT03125889 – Acute Hemostasis Following the Use of the AquaBeam® System for the Treatment of Benign Prostatic Hyperplasia II (AHA II)
8. NCT04308070 – Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia III (AHAIII)
9. ACTRN12613000167763 – Aquablation Pilot Study for the treatment of Benign Prostatic Hyperplasia.

Aquablation therapy has been studied in nine different clinical trials. It has been shown to be a safe and effective treatment for patients suffering from lower urinary tract symptoms (LUTS) due to BPH. Aquablation therapy can be performed on prostates of any size.

For more information, visit the Aquablation Therapy page.

References:
1. NCT03191734 – French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue
2. NCT03123250 – Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II (WATERII)
3. NCT02974751 – Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (OPEN WATER)
4. NCT02505919 -Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)
5. NCT03167294 – AquaBeam India Study for the Treatment of Benign Prostatic Hyperplasia (ABS)
6. NCT03125863 – Acute Hemostasis Following the Use of the AquaBeam® System for the Treatment of Benign Prostatic Hyperplasia (AHA)
7. NCT03125889 – Acute Hemostasis Following the Use of the AquaBeam® System for the Treatment of Benign Prostatic Hyperplasia II (AHA II)
8. NCT04308070 – Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia III (AHAIII)
9. ACTRN12613000167763 – Aquablation Pilot Study for the treatment of Benign Prostatic Hyperplasia.

Once you’re home, you may experience mild burning sensation during urination for a couple of weeks. This can be managed with mild pain medication. Patients can resume their normal activities once approved by their doctor.

Visit our Aquablation Therapy page for more information about the procedure, recovery, and side effects.

The cost of Aquablation therapy will depend on what country you live in and what type of insurance you have. For more information, visit our Insurance page.

For patients in the United States, Medicare and several of the major national private insurance companies have issued positive coverage policies for their patients. For all other private insurance companies, coverage can be assessed on an individual basis, and you should speak with your provider directly to determine if Aquablation therapy is available for you.

For more information, visit our Insurance page.

For patients outside of the United States, reimbursement and coverage vary by geography. We recommend patients contact their local physician providers to determine if Aquablation therapy is available.

For more information, visit our Insurance page.

The AquaBeam Robotic System performs Aquablation therapy. For more information about what happens during Aquablation therapy, visit the Aquablation Therapy page.

Aquablation therapy is a one-of-a-kind procedure. It is the only procedure that uses a heat-free waterjet controlled by robotic technology to remove prostate tissue and combines a camera (called a cystoscope) with ultrasound imaging, giving the surgeon the ability to see the entire prostate in real time. As a result, Aquablation therapy is precise, consistent and predictable and provides long-term relief no matter how large your prostate is. It has a very low rate of irreversible complications—incontinence, ejaculatory dysfunction, erectile dysfunction.^1,2

For more information, visit our Aquablation Therapy page.

References:
1. Gilling, P, et al. Three-Year Outcomes after Aquablation Therapy Compared to TURP: Results from a Blinded Randomized Trial. Can J Urol. 2020 Feb;27(1):10072-10079.
2. Bhojani, N, et al.  Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results. Urology. 2019 Jul;129:1-7.

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only